<info type="ChemicalEntity">Daidzein</info> activates <info type="GeneOrGeneProduct">choline acetyltransferase</info> from <info type="CellLine">MC-IXC cells</info> and improves drug-induced <info type="DiseaseOrPhenotypicFeature">amnesia</info>.

The <info type="GeneOrGeneProduct">choline acetyltransferase</info> (<info type="GeneOrGeneProduct">ChAT</info>) activator, which enhances <info type="GeneOrGeneProduct">cholinergic transmission</info> via an augmentation of the enzymatic production of <info type="ChemicalEntity">acetylcholine</info> (<info type="ChemicalEntity">ACh</info>), is an important factor in the treatment of <info type="DiseaseOrPhenotypicFeature">Alzheimer's disease</info> (<info type="DiseaseOrPhenotypicFeature">AD</info>). <info type="ChemicalEntity">Methanolic extracts</info> from <info type="OrganismTaxon">Pueraria thunbergiana</info> exhibited an activation effect (46%) on <info type="GeneOrGeneProduct">ChAT</info> in vitro. Via the sequential isolation of <info type="OrganismTaxon">Pueraria thunbergiana</info>, the active component was ultimately identified as <info type="ChemicalEntity">daidzein</info> (<info type="ChemicalEntity">4',7-dihydroxy-isoflavone</info>). In order to investigate the effects of <info type="ChemicalEntity">daidzein</info> from <info type="OrganismTaxon">Pueraria thunbergiana</info> on <info type="DiseaseOrPhenotypicFeature">scopolamine-induced impairments of learning and memory</info>, we conducted a series of in vivo tests. Administration of <info type="ChemicalEntity">daidzein</info> (4.5 mg/kg body weight) to <info type="OrganismTaxon">mice</info> was shown significantly to reverse <info type="DiseaseOrPhenotypicFeature">scopolamine-induced amnesia</info>, according to the results of a <info type="GeneOrGeneProduct">Y-maze test</info>. Injections of <info type="ChemicalEntity">scopolamine</info> into <info type="OrganismTaxon">mice</info> resulted in impaired performance on <info type="GeneOrGeneProduct">Y-maze tests</info> (a 37% decreases in alternation behavior). By way of contrast, <info type="OrganismTaxon">mice</info> treated with <info type="ChemicalEntity">daidzein</info> prior to the <info type="ChemicalEntity">scopolamine</info> injections were noticeably protected from this performance impairment (an approximately 12%-21% decrease in alternation behavior). These results indicate that <info type="ChemicalEntity">daidzein</info> might play a role in <info type="ChemicalEntity">acetylcholine</info> biosynthesis as a <info type="GeneOrGeneProduct">ChAT</info> activator, and that it also ameliorates <info type="DiseaseOrPhenotypicFeature">scopolamine-induced amnesia</info>.